Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.
Clinical trial NCT03460743 · COMPLETED
Trial details
- NCT number
- NCT03460743
- Sponsor
- Laboratorios Liomont
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2019-10-22
- Enrollment
- 1556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.